Polycystic ovarian syndrome: Is community care appropriate?

International Journal of Clinical Practice

Volumn 53, Issue 5, 1999, Pages 359-362

  Gupta, Sunanda ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE; CYPROTERONE ACETATE; DIANE; FINASTERIDE; FLUTAMIDE; GESTAGEN; GONADORELIN AGONIST; GONADOTROPIN; MEDROXYPROGESTERONE ACETATE; METFORMIN; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL PAIN; ACNE; AMENORRHEA; ANOVULATION; ARTICLE; CAUTERIZATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIATHERMY; DYSLIPIDEMIA; FEMALE; FEMALE INFERTILITY; HIRSUTISM; HOT FLUSH; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY DIAGNOSIS; LASER SURGERY; LIVER TOXICITY; MASTALGIA; MENSTRUATION DISORDER; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RASH; SPONTANEOUS ABORTION; ULTRASOUND; VISUAL DISORDER;

ABORTION, SPONTANEOUS; COMMUNITY HEALTH SERVICES; FEMALE; HIRSUTISM; HUMANS; MENSTRUATION DISTURBANCES; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRIMARY HEALTH CARE; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION;

EID: 0032791871     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Stein IF, Leventhal ML. Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191.
2. Polson DW, Wadsworth J, Adams J et al. Polycystic ovaries: a common finding in normal women. Lancet 1988; i: 870-872.
3. Dunaif A. Insulin resistance and the polycystic ovarian syndrome: mechanisms and implication for pathogenesis. Endocr Rev 1997; 12: 774-800.
4. Corey AH, Chan KL, Short F et al. Evidence of a single gene effect causing polycystic ovaries and male pattern of baldness. Clin Endocrinol 1993; 38: 653-658.
5. Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and ideopathic hirsutism. BMJ Clin Res 1989; 293: 355-359.
6. Timpatanapong P, Rojainasakkaul A. Hormonal profiles and prevalence of polycystic ovarian syndrome in women with acne. J Dermatol 1997; 24(4): 223-229.
7. Fox R, Comigan E, Thomas P et al. Oestrogen and androgen states in oligoamenorrhoeic women with polycystic ovarian syndrome. Br J Obstet Gynaecol 1991; 98: 294-298.
8. Conway GS, Harour JW, Jacobs HS. Heterogenicity of the polycystic ovarian syndrome: clinical, endocrine and US features in 556 patients. Clin Endocrinol 1989; 30: 459-470.
9. Grulet H, Hecart A C, Delemer B et al. Roles of luteinising hormone and insulin resistance in lean and obese polycystic ovarian syndrome. Clin Endocrinol 1993; 38: 621-626.
10. Robinson S, Kiddy D, Gelding SV et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol 1993; 39(3): 351.
11. Meirow D, Raz, Bsezinski A et al. Dyslipidemia in polycystic ovarian syndrome: different groups, different etiologies? Hum Reproduc 1996; 11(9): 1848-1853.
12. Jialal I, Naiker P, Reddi K et al. Evidence for insulin resistance in non obese patients with PCOD. Clin Endocrinol Metab 1987; 64: 1066-1069.
13. Sampson M, Kong C, Patel A et al. Ambulatory blood pressure profiles and PA I-1 activity in lean women with anovulatory polycystic ovarian syndrome. Clin Endocrinol 1996; 45(5): 623-629.
14. Wild RA, Grubb B, Hartz A et al. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril 1990; 45: 255-259.
15. Birdsall MA, Farquihar CM, White HD. Association between polycystic ovarian syndrome and extent of coronary heart disease in women having cardiac catheterization. Ann Intern Med 1997; 126: 32-35.
16. Dahlgren E, Johansson S, Lindstedt G et al. Women with PCOS wedge re-sected in 1956 to 1965: a long term follow up focusing on natural history and circulating hormones. Fertil Steril 1992; 57: 505-513.
17. Dixon JE, Rodin A, Murby B, Chapman MG. Bone mass in hirsute women with androgen excess. Clin Endocrinol 1989; 30: 271-77.
18. Kaales R. Nutrition, hormones and breast cancer: is insulin the missing link? Cancer, Causes Control 1996; 7(6): 605-625.
19. Hollman M, Runnebaum B, Gerhard I, Effeck T. Effects of weight loss on the hormonal profile in obese, infertile women. Hum Reprod 1996; 11: 1884-1891.
20. Nagmani M, Hannigan EV, Dinh LTV et al. Hyperstimulation and stromel luteinisation of ovaries in post-menopausal women with endometrial cancer. J Clin Endocrinol Metab 1988; 67: 144-148.
21. Velazquez EM, Acosta A, Mendoza SG et al. Menstrual cyclicity after metformin therapy in polycystic ovarian syndrome. Obstet Gynecol 1997; 90: 392-395.
22. Jacobs HS. Hirsutism. Curr Obstet Gynaecol 1992; 1: 217-220.
23. Cusan L, Dupont A, Gomez J et al. Comparison of flutamide and spironolactone in the treatment of hirsutism. Fertil Steril 1994; 61: 281-287.
24. Nestler JE, Jakubowicz D\J. Decrease in ovarian cytochrome P450 C17 activity and serum free testosterone after reduction of insulin secretion in PCOS. N Engl J Med 1996; 335: 617-623.
25. Kiddy DS, Hamilton Fairley D, Bush A et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovarian syndrome. Clin Endocrinol 1992; 36: 105-111.
26. ESHRE Capri workshop. Female infertility: treatment options for complicated cases. Hum Reprod 1997; 12: 1191-1196.
27. Kousta E, White DM, Franks S. Modern use of clomiphene citrate in induction of ovulation. Hum Reprod Update 1997; 3: 359-365
28. Rossing MA, Daling JR, Weiss NS et al. Ovarian tumour in a cohort of infertile women. N Engl J Med 1994; 331: 771-776.
29. Balen AH, Jacobs HS. Ovulation induction. In: Balen AH, Jacobs HS, Eds. Infertility in practice. Edinburgh: Churchill Livingstone, 1997; 131.
30. Doneshy BW, Adashi EY. Surgical ovulation induction: the role of ovarian diathermy in PCOS. Baillière's Clin Obstet Gynecol 1996; 10: 293-309.
31. Regan L, Owen EJ, Jacobs HS. Hypersecretion of LH, infertility and miscarriage. Lancet 1990; 336: 1141-1143.